These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 28652022

  • 1. CHSY1 promotes aggressive phenotypes of hepatocellular carcinoma cells via activation of the hedgehog signaling pathway.
    Liu CH, Lan CT, Chou JF, Tseng TJ, Liao WC.
    Cancer Lett; 2017 Sep 10; 403():280-288. PubMed ID: 28652022
    [Abstract] [Full Text] [Related]

  • 2. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT, Zhou JW, Li DK, Chen ZT, Chen ZQ, Hu SY.
    Liver Int; 2015 Apr 10; 35(4):1416-29. PubMed ID: 25066210
    [Abstract] [Full Text] [Related]

  • 3. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
    Wu YM, Liu CH, Hu RH, Huang MJ, Lee JJ, Chen CH, Huang J, Lai HS, Lee PH, Hsu WM, Huang HC, Huang MC.
    Cancer Res; 2011 Dec 01; 71(23):7270-9. PubMed ID: 21990321
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD, Sun XJ, Yin JJ, Yin M, Wang W, Nie ZQ, Xu J.
    Biomed Pharmacother; 2018 Oct 01; 106():134-141. PubMed ID: 29957463
    [Abstract] [Full Text] [Related]

  • 6. The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target.
    Qin CD, Ma DN, Zhang SZ, Zhang N, Ren ZG, Zhu XD, Jia QA, Chai ZT, Wang CH, Sun HC, Tang ZY.
    Cell Death Dis; 2018 May 01; 9(5):486. PubMed ID: 29706627
    [Abstract] [Full Text] [Related]

  • 7. Targeting Chondroitin Sulfate Reduces Invasiveness of Glioma Cells by Suppressing CD44 and Integrin β1 Expression.
    Chu YH, Liao WC, Ho YJ, Huang CH, Tseng TJ, Liu CH.
    Cells; 2021 Dec 20; 10(12):. PubMed ID: 34944101
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-β signaling-induced epithelial-mesenchymal transition.
    Qiu C, Liu Y, Mei Y, Zou M, Zhao Z, Ye M, Wu X.
    Aging (Albany NY); 2018 Oct 18; 10(10):2783-2799. PubMed ID: 30335615
    [Abstract] [Full Text] [Related]

  • 11. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH, Yu CC, Lin YS, Chen TC, Yeh CT, Liang KH, Shieh TM, Chen CY, Hsueh C.
    Oncotarget; 2016 Jul 12; 7(28):43588-43603. PubMed ID: 27248828
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R, Wu S, Lv X, Fang H, Wu S, Kang J.
    J Exp Clin Cancer Res; 2014 Dec 14; 33(1):105. PubMed ID: 25499255
    [Abstract] [Full Text] [Related]

  • 13. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.
    World J Gastroenterol; 2015 Jan 07; 21(1):196-213. PubMed ID: 25574092
    [Abstract] [Full Text] [Related]

  • 14. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
    Leng C, Zhang ZG, Chen WX, Luo HP, Song J, Dong W, Zhu XR, Chen XP, Liang HF, Zhang BX.
    Cancer Lett; 2016 Jun 28; 376(1):188-96. PubMed ID: 26996299
    [Abstract] [Full Text] [Related]

  • 15. FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling.
    Yang G, Liang Y, Zheng T, Song R, Wang J, Shi H, Sun B, Xie C, Li Y, Han J, Pan S, Lan Y, Liu X, Zhu M, Wang Y, Liu L.
    Cancer Lett; 2016 Aug 10; 378(2):80-6. PubMed ID: 27177473
    [Abstract] [Full Text] [Related]

  • 16. Forkhead-box R2 promotes metastasis and growth by stimulating angiogenesis and activating hedgehog signaling pathway in ovarian cancer.
    Li B, Huang W, Cao N, Lou G.
    J Cell Biochem; 2018 Sep 10; 119(9):7780-7789. PubMed ID: 29943836
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of Rab17 promotes tumourigenic properties of hepatocellular carcinoma cells via Erk pathway.
    Qi J, Zhao P, Li F, Guo Y, Cui H, Liu A, Mao H, Zhao Y, Zhang X.
    Int J Clin Exp Pathol; 2015 Sep 10; 8(5):4963-71. PubMed ID: 26191189
    [Abstract] [Full Text] [Related]

  • 18. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway.
    Yuan S, Gong Y, Chen R, Du J, Zhang H, Chen T.
    Biomed Pharmacother; 2020 Dec 10; 132():110867. PubMed ID: 33075668
    [Abstract] [Full Text] [Related]

  • 19. Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway.
    Chan KK, Leung CO, Wong CC, Ho DW, Chok KS, Lai CL, Ng IO, Lo RC.
    Cancer Lett; 2017 Sep 10; 403():330-338. PubMed ID: 28688970
    [Abstract] [Full Text] [Related]

  • 20. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo.
    Lu HY, Chu HX, Tan YX, Qin XC, Liu MY, Li JD, Ren TS, Zhang YS, Zhao QC.
    Life Sci; 2020 Mar 01; 244():117343. PubMed ID: 31978449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.